Dr. Arwa Nada
Associate Professor, Pediatrics. Chief, Division of Pediatric Nephrology
Loma Linda Children’s Hospital, LLU
Dr. Arwa Nada is a dual-trained pediatric nephrologist and academic leader whose career spans two continents and is defined by clinical excellence, innovation, and a deep commitment to advancing pediatric kidney care. She completed her MBBCh and MSc at the University of Alexandria, one of Egypt’s most prestigious medical schools and consistently ranked among the top universities in the country. During her pediatric residency at El-Shatby Children’s Hospit, the primary teaching hospital of the University of Alexandria, Dr. Nada developed her clinical foundation and began her academic career as an Assistant Lecturer in Pediatric Nephrology, actively engaged in teaching and bedside research.
After relocating to the United States, Dr. Nada completed a second pediatric residency at Nassau University Medical Center affiliated with LIJ Hospital) in New York and a fellowship in pediatric nephrology at Nationwide Children’s Hospital in Ohio. Her dual training experience gave her a distinctive global perspective and a systems-based approach to both care delivery and medical education.
Currently, Dr. Nada serves as Chief of the Division of Pediatric Nephrology at Loma Linda University Children’s Hospital and Associate Professor of Pediatrics at Loma Linda University. She previously held numerous leadership positions at the University of Tennessee Health Science Center, including Fellowship Program Director, Peds Nephrology Clerkship Director, and Director of several cross-disciplinary educational initiatives.
Dr. Nada’s clinical innovation includes establishing one of the first Newborn Kidney Clinics in the U.S., as well as designing and implementing EMR-integrated quality improvement tools that have improved detection and documentation of AKI, optimized immunization practices for immunocompromised children, supported ABPM adoption, and reduced care gaps in children with chronic kidney disease and kidney trasnplant children.
Her research contributions are extensive and impactful. Dr. Nada serves as the principal investigator of the Neonatal & Infant Kidney Support Therapy (NIKST) international registry, and her peer-reviewed work includes more than 60 publications spanning neonatal nephrology, acute kidney injury, onco-nephrology, and the integration of artificial intelligence into pediatric clinical practice. Her landmark two-part review on onco-nephrology remains one of the most comprehensive in the field.
She is certified by the American Board of Artificial Intelligence in Medicine (ABAiM) and also holds the UTHSC Clinical Educator Certification and the UTHSC Diversity & Inclusion Certificate, demonstrating her sustained commitment to excellence in teaching, inclusive care, and transformative innovation.
Dr. Nada is deeply invested in advancing the field of pediatric nephrology through national leadership. She served as chair of the ASPN Workforce Committee and is currently the Chair of ASPN Quality Improvement & Artificial Intelligence Special Interest Group, and leads the ASPN National Pediatric Nephrology Lecture Series, providing high-quality education to fellows across North America. She is also a member of multiple national and international working groups, including the Pediatric CRRT ICONIC Collaborative, Neonatal Kidney Collaborative, and the International Pediatric Nephrology Association.
Her work has been recognized with numerous awards, including the Castle Connolly Top Doctor and Elite Top Doctor honors (2024), the AIMed Rising Star in AI Award (2024), and multiple national travel and research awards during fellowship and early faculty years. Her quality improvement project utilizing AI for neonatal AKI detection earned funding and institutional recognition at Le Bonheur Children’s Hospital.
A frequent invited speaker at national and international conferences—including PAS, IPNA, ASN, and AIMed—Dr. Nada continues to shape the future of pediatric nephrology by integrating her global medical roots, advanced informatics expertise, and strong faculty leadership into a cohesive, forward-thinking vision for child health.
After relocating to the United States, Dr. Nada completed a second pediatric residency at Nassau University Medical Center affiliated with LIJ Hospital) in New York and a fellowship in pediatric nephrology at Nationwide Children’s Hospital in Ohio. Her dual training experience gave her a distinctive global perspective and a systems-based approach to both care delivery and medical education.
Currently, Dr. Nada serves as Chief of the Division of Pediatric Nephrology at Loma Linda University Children’s Hospital and Associate Professor of Pediatrics at Loma Linda University. She previously held numerous leadership positions at the University of Tennessee Health Science Center, including Fellowship Program Director, Peds Nephrology Clerkship Director, and Director of several cross-disciplinary educational initiatives.
Dr. Nada’s clinical innovation includes establishing one of the first Newborn Kidney Clinics in the U.S., as well as designing and implementing EMR-integrated quality improvement tools that have improved detection and documentation of AKI, optimized immunization practices for immunocompromised children, supported ABPM adoption, and reduced care gaps in children with chronic kidney disease and kidney trasnplant children.
Her research contributions are extensive and impactful. Dr. Nada serves as the principal investigator of the Neonatal & Infant Kidney Support Therapy (NIKST) international registry, and her peer-reviewed work includes more than 60 publications spanning neonatal nephrology, acute kidney injury, onco-nephrology, and the integration of artificial intelligence into pediatric clinical practice. Her landmark two-part review on onco-nephrology remains one of the most comprehensive in the field.
She is certified by the American Board of Artificial Intelligence in Medicine (ABAiM) and also holds the UTHSC Clinical Educator Certification and the UTHSC Diversity & Inclusion Certificate, demonstrating her sustained commitment to excellence in teaching, inclusive care, and transformative innovation.
Dr. Nada is deeply invested in advancing the field of pediatric nephrology through national leadership. She served as chair of the ASPN Workforce Committee and is currently the Chair of ASPN Quality Improvement & Artificial Intelligence Special Interest Group, and leads the ASPN National Pediatric Nephrology Lecture Series, providing high-quality education to fellows across North America. She is also a member of multiple national and international working groups, including the Pediatric CRRT ICONIC Collaborative, Neonatal Kidney Collaborative, and the International Pediatric Nephrology Association.
Her work has been recognized with numerous awards, including the Castle Connolly Top Doctor and Elite Top Doctor honors (2024), the AIMed Rising Star in AI Award (2024), and multiple national travel and research awards during fellowship and early faculty years. Her quality improvement project utilizing AI for neonatal AKI detection earned funding and institutional recognition at Le Bonheur Children’s Hospital.
A frequent invited speaker at national and international conferences—including PAS, IPNA, ASN, and AIMed—Dr. Nada continues to shape the future of pediatric nephrology by integrating her global medical roots, advanced informatics expertise, and strong faculty leadership into a cohesive, forward-thinking vision for child health.
